Lung Cancer Network Malaysia introduces Malaysia’s first-ever digital lung cancer patient guide, to provide an up-to-date guide for patients and their loved ones.
The National Cancer Society of Malaysia says cancer screenings declined by over 80% in Malaysia as a result of the Covid-19 pandemic, which will result in higher cancer morbidity and mortality.
The financial burden that comes along with cancer is high, forcing some patients to take their medication irregularly so that they don’t have to purchase new medication so soon.
Subang Jaya Medical Centre, in collaboration with AstraZeneca and Pfizer, has launched a patient access programme to provide genetic next generation sequencing of their lung cancer at substantially reduced costs.